Research Topics
| Kevin A SchulmanSummaryAffiliation: Duke University Medical Center Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Stage migration, selection bias, and survival associated with the adoption of positron emission tomography among medicare beneficiaries with non-small-cell lung cancer, 1998-2003Michaela A Dinan
Duke Clinical Research Institute, PO Box 17969, Durham, NC 27715, USA
J Clin Oncol 30:2725-30. 2012..However, this association may be confounded by PET-induced stage migration and selection bias. We examined the association between PET use and overall survival among Medicare beneficiaries with NSCLC...
Economic implications of potential changes to regulatory and reimbursement policies for medical devicesShelby D Reed
Center for Clinical and Genetic Economics, Duke Clinical Research Institute, PO Box 17969, Durham, NC 27715, USA
J Gen Intern Med 23:50-6. 2008..To evaluate the impact of regulatory scenarios on the financial viability of medical device companies...
Parents' reported preference scores for childhood atopic dermatitis disease statesJoelle Y Friedman
Center for Clinical and Genetic Economics, Duke Clinical Research Institute, Duke University Medical Center, PO Box 17969, Durham, NC 27715, USA
BMC Pediatr 4:21. 2004....
Sensitivity of International Classification of Diseases codes for hyponatremia among commercially insured outpatients in the United StatesAlisa M Shea
Center for Clinical and Genetic Economics, Duke Clinical Research Institute, PO Box 17969, Durham, North Carolina, USA
BMC Nephrol 9:5. 2008....
A national survey of provisions in clinical-trial agreements between medical schools and industry sponsorsKevin A Schulman
Center for Clinical and Genetic Economics, Duke University Medical Center, Durham, NC, USA
N Engl J Med 347:1335-41. 2002..It is unclear whether research conducted at academic institutions adheres to these new standards...
Toward estimating the impact of changes in immigrants' insurance eligibility on hospital expenditures for uncompensated careLiana D Castel
Center for Clinical and Genetic Economics, Duke Clinical Research Institute, Duke University Medical Center, PO Box 17969, Durham, NC 27715 USA
BMC Health Serv Res 3:1. 2003..Our goal was to assess the effect of PRWORA on hospital uncompensated care in the United States...
A policy approach to the development of molecular diagnostic testsKevin A Schulman
Duke Clinical Research Institute, Duke University School of Medicine and the Health Sector Management Program, The Fuqua School of Business, Duke University, Durham, North Carolina, USA
Nat Biotechnol 28:1157-9. 2010..A new approach to reimbursement in the United States offers a balance between evidence and incentives for molecular diagnostic tests...
Outcomes research in oncology: improving patients' experiences with cancer treatmentKevin A Schulman
Center for Clinical and Genetic Economics, Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina 27715, USA
Clin Ther 25:665-70. 2003..In doing so, we introduce the articles in this supplemental section, which address some of the unique concerns of outcomes researchers and outline the most important challenges confronting this research community...
Patient reactions to confidentiality, liability, and financial aspects of informed consent in cardiology researchAlice K Fortune-Greeley
Center for Clinical and Genetic Economics, Duke University School of Medicine, Durham, NC 27715, USA
Circ Cardiovasc Qual Outcomes 3:151-8. 2010..We examined the relationship between patients' reactions to standard informed consent language and their willingness to participate in a hypothetical clinical trial...
Resource use, costs, and quality of life among patients in the multinational Valsartan in Acute Myocardial Infarction Trial (VALIANT)Shelby D Reed
Center for Clinical and Genetic Economics, Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27715, USA
Am Heart J 150:323-9. 2005..The difference will be smaller or nonexistent in settings where brand-name ACE inhibitors are prescribed...
Clinical outcomes and costs due to Staphylococcus aureus bacteremia among patients receiving long-term hemodialysisJohn J Engemann
Division of Infectious Diseases, Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA
Infect Control Hosp Epidemiol 26:534-9. 2005..To examine the clinical outcomes and costs associated with Staphylococcus aureus bacteremia among hemodialysis-dependent patients...
Outcomes of Staphylococcus aureus infection in hemodialysis-dependent patientsYanhong Li
Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina, USA
Clin J Am Soc Nephrol 4:428-34. 2009..Staphylococcus aureus is a leading cause of infection in patients with ESRD. Clinical and economic outcomes associated with S. aureus bacteremia and other S. aureus infections in patients with ESRD were examined...
Effects of exercise training on health status in patients with chronic heart failure: HF-ACTION randomized controlled trialKathryn E Flynn
Center for Clinical and Genetic Economics, Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC 27715, USA
JAMA 301:1451-9. 2009..Findings from previous studies of the effects of exercise training on patient-reported health status have been inconsistent...
Alternative pay-for-performance scoring methods: implications for quality improvement and patient outcomesSeth W Glickman
Center for Clinical and Genetic Economics, Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina, USA
Med Care 47:1062-8. 2009..Alternative methods that weight process measures according to how hospitals organize care and the range for possible improvement may be more closely related to patient outcomes...
Association between the Medicare Modernization Act of 2003 and patient wait times and travel distance for chemotherapyAlisa M Shea
Center for Clinical and Genetic Economics, Duke Clinical Research Institute, PO Box 17969, Durham, NC 27715, USA
JAMA 300:189-96. 2008..Anecdotal reports suggest that these adjustments may have negatively affected access to chemotherapy for Medicare beneficiaries...
Outcomes, health policy, and managed care: relationships between patient-reported outcome measures and clinical measures in outpatients with heart failureKathryn E Flynn
Center for Clinical and Genetic Economics, Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC 27715, USA
Am Heart J 158:S64-71. 2009..We examined associations between patient-reported measures of health-related quality of life and clinical indicators of disease severity in a large, heterogeneous sample of patients with heart failure...
Patient satisfaction and its relationship with clinical quality and inpatient mortality in acute myocardial infarctionSeth W Glickman
Center for Clinical and Genetic Economics, Duke University, Durham, NC, USA
Circ Cardiovasc Qual Outcomes 3:188-95. 2010..The objective of this study was to determine whether patient satisfaction is associated with adherence to practice guidelines and outcomes for acute myocardial infarction and to identify the key drivers of patient satisfaction...
Perceived racial/ethnic bias in healthcare in Durham County, North Carolina: a comparison of community and national samplesJoelle Y Friedman
Center for Clinical and Genetic Economics, Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27715, USA
N C Med J 66:267-75. 2005..We sought to compare findings of a national survey of perceptions of racial/ethnic discrimination in healthcare to those of a community survey, with emphasis on the perceptions of Latinos...
Relationships between emerging measures of heart failure processes of care and clinical outcomesAdrian F Hernandez
Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA
Am Heart J 159:406-13. 2010..Previous studies have not confirmed associations between some current performance measures for inpatient heart failure processes of care and postdischarge outcomes. It is unknown if alternative measures are associated with outcomes...
Resource use in the last 6 months of life among medicare beneficiaries with heart failure, 2000-2007Kathleen T Unroe
Duke Clinical Research Institute, Durham, NC 27715, USA
Arch Intern Med 171:196-203. 2011..Heart failure is a common cause of death among Medicare beneficiaries, but little is known about health care resource use at the end of life...
A framework for quality improvement: an analysis of factors responsible for improvement at hospitals participating in the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the ACC/AHA GuidelinSeth W Glickman
Center for Clinical and Genetic Economics, Duke University Medical Center, Durham, NC, USA
Am Heart J 154:1206-20. 2007....
Geographic variation in the treatment of acute myocardial infarction in the VALsartan In Acute myocardial iNfarcTion (VALIANT) trialShelby D Reed
Center for Clinical and Genetic Economics, Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA
Am Heart J 152:500-8. 2006..Our findings have implications not only for care of patients but also for the conduct of international trials...
Cost-effectiveness of imatinib versus interferon-alpha plus low-dose cytarabine for patients with newly diagnosed chronic-phase chronic myeloid leukemiaShelby D Reed
Center for Clinical and Genetic Economics, Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina, USA
Cancer 101:2574-83. 2004..CONCLUSIONS: The results of the current study demonstrate that compared with IFN+LDAC, imatinib is a cost-effective first-line therapy in patients with newly diagnosed chronic-phase CML...
In-hospital resource use and medical costs in the last year of life by mode of death (from the HF-ACTION randomized controlled trial)Shelby D Reed
Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina, USA
Am J Cardiol 110:1150-5. 2012..In conclusion, resource use and associated medical costs in the last year of life differed markedly in patients with HF who experienced SCD and patients who died of other causes...
Relationship between clinical outcomes and vascular access type among hemodialysis patients with Staphylococcus aureus bacteremiaJula K Inrig
Department of Medicine, Division of Nephrology, Duke University Medical Center, Durham, NC 27705, USA
Clin J Am Soc Nephrol 1:518-24. 2006..Twelve-week mortality and costs that are associated with an episode of SAB are high in hemodialysis patients, regardless of vascular access type. Efforts should focus on the prevention of SAB in this high-risk group...
Racial differences in health concernCorrine I Voils
Center for Health Services Research in Primary Care, Durham Veterans Affairs Medical Center, 508 Fulton St, Durham, NC 27705, USA
J Natl Med Assoc 98:36-42. 2006..Interventions to inform blacks and Latinos about their health risks must strike a balance between creating enough health concern to encourage health behavior but not so much that it interferes with health-promoting behaviors...
Comparison of conflict of interest policies and reported practices in academic medical centers in the United StatesMichaela A Dinan
Center for Clinical and Genetic Economics, Duke Clinical Research Institute, Durham, NC 27715, USA
Account Res 13:325-42. 2006..Considerable differences in understanding of conflict of interest policies were observed between IRB and COIC officials...
Long-term costs and resource use in elderly participants with congestive heart failure in the Cardiovascular Health StudyLawrence Liao
Duke Clinical Research Institute, Durham, NC, USA
Am Heart J 153:245-52. 2007..In a prospective, longitudinal cohort of community-dwelling elderly from 4 regions, we examined the long-term costs and resource use of elderly patients with HF...
Staphylococcus aureus bacteremia in patients with prosthetic devices: costs and outcomesVivian H Chu
Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA
Am J Med 118:1416. 2005..aureus bacteremia on patients with prosthetic devices. This investigation sought to define the clinical outcome, health care resource use, and infection-associated costs of S. aureus bacteremia in patients with prostheses...
Long-term outcomes and costs of ventricular assist devices among Medicare beneficiariesAdrian F Hernandez
Duke Clinical Research Institute, PO Box 17969, Durham, NC 27715, USA
JAMA 300:2398-406. 2008..In 2003, Medicare expanded coverage of ventricular assist devices as destination, or permanent, therapy for end-stage heart failure. Little is known about the long-term outcomes and costs associated with these devices...
Clopidogrel use and clinical events after drug-eluting stent implantation: findings from the HealthCore Integrated Research DatabaseJohn L Petersen
Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA
Am Heart J 159:462-470.e1. 2010..Relationships between long-term use and level of dual antiplatelet therapy and outcomes after drug-eluting stent implantation are not well established...
Perceived discrimination and reported delay of pharmacy prescriptions and medical testsCourtney Harold Van Houtven
Center for Health Services Research in Primary Care, Durham Veterans Affairs Medical Center, Durham, NC 27705, USA
J Gen Intern Med 20:578-83. 2005..Access to health care varies according to a person's race and ethnicity. Delaying treatment is one measure of access with important health consequences...
Treatment patterns for neovascular age-related macular degeneration: analysis of 284 380 medicare beneficiariesLesley H Curtis
Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC 27715, USA
Am J Ophthalmol 153:1116-24.e1. 2012..To examine trends in the treatment of newly diagnosed neovascular age-related macular degeneration (AMD)...
Factors influencing the participation of gastroenterologists and hepatologists in clinical researchAnouk T Dev
Duke Clinical Research Institute, PO Box 17969, Durham, North Carolina, USA
BMC Health Serv Res 8:208. 2008..We examined factors that influence the participation of gastroenterologists and hepatologists in clinical research...
Resource use and costs associated with diabetic macular edema in elderly personsAlisa M Shea
Center for Clinical and Genetic Economics, Duke Clinical Research Institute, Durham, NC 27715, USA
Arch Ophthalmol 126:1748-54. 2008..To examine trends in resource use and the effect of incident diabetic macular edema (DME) on 1- and 3-year total direct medical costs in elderly patients...
Geographic variation in carotid revascularization among Medicare beneficiaries, 2003-2006Manesh R Patel
Center for Clinical and Genetic Economics, Duke Clinical Research Institute, Durham, NC 27715, USA
Arch Intern Med 170:1218-25. 2010..We examined geographic variation in and predictors of carotid endarterectomy and carotid stenting...
Clinical effectiveness of implantable cardioverter-defibrillators among medicare beneficiaries with heart failureAdrian F Hernandez
Duke Clinical Research Institute, Department of Medicine, Duke University School of Medicine, Durham, NC, USA
Circ Heart Fail 3:7-13. 2010..The clinical effectiveness of implantable cardioverter-defibrillators (ICDs) in older patients with heart failure has not been established, and older patients have been underrepresented in previous studies...
Outcomes of second revascularization procedures after stent implantationRichard P Konstance
Department of Medicine, Duke University Medical Center, Durham, NC, USA
J Med Syst 32:177-86. 2008..Further studies are needed to determine the optimum application for CABG vs. DES as a second or third revascularization procedure...
Costs of inpatient care among Medicare beneficiaries with heart failure, 2001 to 2004David J Whellan
Center for Clinical and Genetic Economics, Duke University School of Medicine, Durham, NC, USA
Circ Cardiovasc Qual Outcomes 3:33-40. 2010..Inpatient care is the primary driver of costs for patients with heart failure. It is unclear whether recent advances in heart failure care have reduced the costs to Medicare for the care of inpatients with heart failure...
Evidence-based therapies and mortality in patients hospitalized in December with acute myocardial infarctionTrip J Meine
Duke University Medical Center, Durham, North Carolina, USA
Ann Intern Med 143:481-5. 2005..CONCLUSIONS: Thirty-day mortality rates were higher for Medicare patients hospitalized with acute MI in December than in other months, although the use of evidence-based therapies was not significantly lower...
Process of care performance measures and long-term outcomes in patients hospitalized with heart failureMark E Patterson
Center for Clinical and Genetic Economics, Duke University School of Medicine, Durham, NC, USA
Med Care 48:210-6. 2010..Recent efforts to improve care for patients hospitalized with heart failure have focused on process-based performance measures. Data supporting the link between current process measures and patient outcomes are sparse...
Consistency of financial interest disclosures in the biomedical literature: the case of coronary stentsKevin P Weinfurt
Duke Clinical Research Institute, Duke Translational Medicine Institute, Duke University School of Medicine, Durham, North Carolina, United States of America
PLoS ONE 3:e2128. 2008..We examined whether authors' financial interests were disclosed consistently in articles on coronary stents published in 2006...
Prevalence of atypical antipsychotic drug use among commercially insured youths in the United StatesLesley H Curtis
Center for Clinical and Genetic Economics, Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27715, USA
Arch Pediatr Adolesc Med 159:362-6. 2005..Understanding the long-term effects on the developing brain of early and prolonged exposure to atypical antipsychotics is crucial given their use in pediatric populations...
Economic evaluation of zoledronic acid versus pamidronate for the prevention of skeletal-related events in metastatic breast cancer and multiple myelomaShelby D Reed
Center for Clinical and Genetic Economics, Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina, USA
Am J Clin Oncol 28:8-16. 2005..There were no significant cost differences between patients receiving zoledronic acid and those receiving pamidronate...
Policies of academic medical centers for disclosing financial conflicts of interest to potential research participantsKevin P Weinfurt
Center for Clinical and Genetic Economics, Duke Clinical Research Institute, P O Box 17969, Durham, NC 27715, USA
Acad Med 81:113-8. 2006....
Incidence and prevalence of heart failure in elderly persons, 1994-2003Lesley H Curtis
Center for Clinical and Genetic Economics, Duke Clinical Research Institute, Durham, NC 27715, USA
Arch Intern Med 168:418-24. 2008..We sought to estimate the annual incidence and prevalence of heart failure and associated survival in elderly persons from January 1, 1994, through December 31, 2003...
Conducting economic evaluations alongside multinational clinical trials: toward a research consensusShelby D Reed
Center for Clinical and Genetic Economics, Duke University Medical Centre, Durham, NC, USA
Am Heart J 149:434-43. 2005..Delineation of the various approaches to multinational economic evaluation may assist researchers, peer reviewers, journal editors, and decision makers in evaluating the strengths and limitations of particular studies...
Pancreatic beta-cell function as a predictor of cardiovascular outcomes and costs: findings from the Cardiovascular Health StudyLesley H Curtis
Center for Clinical and Genetic Economics, Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC 27715, USA
Curr Med Res Opin 24:41-50. 2008..To explore relationships between beta-cell function and incident cardiovascular events, death, and medical costs among elderly individuals...
Effects of disclosing financial interests on participation in medical research: a randomized vignette trialKevin P Weinfurt
Center for Clinical and Genetic Economics, Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC 27715, USA
Am Heart J 156:689-97. 2008..Little is known about the effects of investigators' financial disclosures on potential research participants...
Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trialCHRISTOPHER M O'CONNOR
Duke Clinical Research Institute, PO Box 17969, Durham, NC 27715, USA
JAMA 301:1439-50. 2009..Guidelines recommend that exercise training be considered for medically stable outpatients with heart failure. Previous studies have not had adequate statistical power to measure the effects of exercise training on clinical outcomes...
Myocardial perfusion, function, and dyssynchrony in patients with heart failure: baseline results from the single-photon emission computed tomography imaging ancillary study of the Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TrAllen E Atchley
Duke University Medical Center, Durham, NC 27710, USA
Am Heart J 158:S53-63. 2009..This article addresses the Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing (HF-ACTION) gated SPECT imaging (gSPECT) substudy baseline results...
Relationship between cardiac rehabilitation and long-term risks of death and myocardial infarction among elderly Medicare beneficiariesBradley G Hammill
Center for Clinical and Genetic Economics, Duke Clinical Research Institute, PO Box 17969, Durham, NC 27715, USA
Circulation 121:63-70. 2010..The relationship between the number of sessions attended and long-term outcomes is unknown...
Costs of vasospasm in patients with aneurysmal subarachnoid hemorrhageChia Hung Chou
Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina, USA
Neurosurgery 67:345-51; discussion 351-2. 2010..To assess the impact of vasospasm on costs, length of stay, and mortality among inpatients with aneurysmal subarachnoid hemorrhage...
Perspective: The case for research justice: inclusion of patients with limited English proficiency in clinical researchSeth W Glickman
University of North Carolina, Chapel Hill, North Carolina, USA
Acad Med 86:389-93. 2011..LEP individuals should have fair access to clinical research in order to fully realize individual and societal benefits of their participation and to ensure the generalizability of scientific discovery...
Relationship between patient satisfaction with inpatient care and hospital readmission within 30 daysWilliam Boulding
The Fuqua School of Business, Duke University, Durham, NC, USA
Am J Manag Care 17:41-8. 2011....
Economic return of clinical trials performed under the pediatric exclusivity programJennifer S Li
Department of Pediatrics, Duke Clinical Research Institute, Duke University, Durham, NC 27705, USA
JAMA 297:480-8. 2007..This critique has been a substantial part of congressional debate on the program, which is due to expire in 2007...
Effects of skeletal morbidities on longitudinal patient-reported outcomes and survival in patients with metastatic prostate cancerVenita Depuy
Center for Clinical and Genetic Economics, Duke Clinical Research Institute, Duke University Medical Center, P O Box 17969, Durham, NC 27715, USA
Support Care Cancer 15:869-76. 2007..We sought to quantify the longitudinal effects on patient-reported outcomes of skeletal-related events (SREs) and to ascertain the declines in health-related quality of life (HRQOL) and pain experienced by patients who experienced SREs...
Atypical antipsychotic drugs and diabetes mellitus in a large outpatient population: a retrospective cohort studyTruls Østbye
Department of Community and Family Medicine, Duke University Medical Center, Durham, NC 27710, USA
Pharmacoepidemiol Drug Saf 14:407-15. 2005..We sought to compare the incidence of new onset diabetes among patients receiving atypical antipsychotics, traditional antipsychotics or antidepressants...
Economic evaluation of weekly epoetin alfa versus biweekly darbepoetin alfa for chemotherapy-induced anaemia: evidence from a 16-week randomised trialShelby D Reed
Center for Clinical and Genetic Economics, Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina 27715, USA
Pharmacoeconomics 24:479-94. 2006..Decision makers must evaluate the differences in costs and efficacy measures that are most relevant from their perspectives...
Costs for heart failure with normal vs reduced ejection fractionLawrence Liao
Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27710, USA
Arch Intern Med 166:112-8. 2006..However, there are few data regarding the costs of HF with normal EF. In a prospective, population-based cohort of elderly participants, we compared the costs and resource use of patients with HF and normal and reduced EF...
Understanding of an aggregate probability statement by patients who are offered participation in Phase I clinical trialsKevin P Weinfurt
Center for Clinical and Genetic Economics, Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina 27715, USA
Cancer 103:140-7. 2005..The authors sought to characterize a special form of numeracy among patients with advanced cancer who were offered participation in Phase I oncology clinical trials...
N-terminal pro-brain natriuretic peptide and exercise capacity in chronic heart failure: data from the Heart Failure and a Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) studyG Michael Felker
Duke Clinical Research Institute, Durham, NC 27705, USA
Am Heart J 158:S37-44. 2009..To examine the relationship between N-terminal pro-brain natriuretic peptide (NT-proBNP) and exercise capacity in a large contemporary cohort of patients with chronic heart failure...
Associations between hemoglobin level, resource use, and medical costs in patients with heart failure: findings from HF-ACTIONShelby D Reed
Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina 27715, USA
J Card Fail 18:784-91. 2012..Reports that patients with heart failure and anemia incur greater costs and medical resource use have relied largely on data with limited clinical detail...
The Medicare Modernization Act and reimbursement for outpatient chemotherapy: do patients perceive changes in access to care?Joeëlle Y Friedman
Center for Clinical and Genetic Economics, Duke Clinical Research Institute, Durham, North Carolina 27715, USA
Cancer 110:2304-12. 2007....
Changes in the use and costs of diagnostic imaging among Medicare beneficiaries with cancer, 1999-2006Michaela A Dinan
Center for Clinical and Genetic Economics, Duke Clinical Research Institute, PO Box 17969, Durham, NC 27715, USA
JAMA 303:1625-31. 2010..Imaging is the fastest growing expense for Medicare but has not been examined among beneficiaries with cancer...
Cost effectiveness of ixabepilone plus capecitabine for metastatic breast cancer progressing after anthracycline and taxane treatmentShelby D Reed
Center for Clinical and Genetic Economics and Outcomes Research and Assessment Group, Duke Clinical Research Institute, PO Box 17969, Durham, NC 27715, USA
J Clin Oncol 27:2185-91. 2009....
Geographic variation in the prescription of schedule II opioid analgesics among outpatients in the United StatesLesley H Curtis
Center for Clinical and Genetic Economics, Duke Clinical Research Institute, P.O. Box 17969, Durham, NC 27715, USA
Health Serv Res 41:837-55. 2006..Future research should use individual-level data to assess whether these findings reflect a reduction in abuse and diversion or suboptimal treatment of pain...
Developing model language for disclosing financial interests to potential clinical research participantsKevin P Weinfurt
Duke University School of Medicine, Durham, NC, USA
IRB 29:1-5. 2007
External validity of the cardiovascular health study: a comparison with the Medicare populationLisa D DiMartino
Center for Clinical and Genetic Economics, Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina 27715, USA
Med Care 47:916-23. 2009..The Cardiovascular Health Study (CHS), a population-based prospective cohort study, has been used to identify major risk factors associated with cardiovascular disease and stroke in the elderly...
Oversight of financial conflicts of interest in commercially sponsored research in academic and nonacademic settingsKevin P Weinfurt
Center for Clinical and Genetic Economics, Duke Clinical Research Institute, Duke University School of Medicine, PO Box 17969, Durham, NC 27715, USA
J Gen Intern Med 25:460-4. 2010..Studies of conflicts of interest in clinical research have focused on academic centers, but most clinical research takes place in nonacademic settings...
Inappropriate prescribing for elderly Americans in a large outpatient populationLesley H Curtis
Center for Clinical and Genetic Economics, Duke Clinical Research Institute, Durham, NC 27715, USA
Arch Intern Med 164:1621-5. 2004..Pharmaceutical claims databases can be important tools for accomplishing this task, though clinical and laboratory data are needed to improve the sensitivity and specificity of patient-specific alerts...
Multinational economic evaluation of valsartan in patients with chronic heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT)Shelby D Reed
Center for Clinical and Genetic Economics, Durham, NC, USA
Am Heart J 148:122-8. 2004..In patients not taking ACE inhibitors, valsartan was economically attractive, increasing survival while reducing or marginally increasing overall costs...
Prostate-specific antigen screening among young men in the United StatesCharles D Scales
Duke Prostate Center, Division of Urology, Department of Surgery, Duke University School of Medicine, Durham, North Carolina 27710, USA
Cancer 113:1315-23. 2008..Little is known about the use of PSA testing in these men. To understand policy implications of risk stratification, the authors sought to characterize PSA use among young men...
Perspectives of clinical research coordinators on disclosing financial conflicts of interest to potential research participantsJoelle Y Friedman
Center for Clinical and Genetic Economics, Duke Clinical Research Institute
Clin Trials 4:272-8. 2007....
Linking inpatient clinical registry data to Medicare claims data using indirect identifiersBradley G Hammill
Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC 27715, USA
Am Heart J 157:995-1000. 2009..We present a method to link hospitalization records from registries with Medicare inpatient claims data, without using direct identifiers, to create a unique data source that pairs rich clinical data with long-term outcome data...
Outcomes of inpatients with and without sickle cell disease after high-volume surgical proceduresMichaela A Dinan
Center for Clinical and Genetic Economics, Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina, USA
Am J Hematol 84:703-9. 2009..Patients with SCD who underwent cholecystectomy or hip replacement required more health care resources than patients without SCD. Am. J. Hematol. 2009. (c) 2009 Wiley-Liss, Inc...
Costs and outcomes among hemodialysis-dependent patients with methicillin-resistant or methicillin-susceptible Staphylococcus aureus bacteremiaShelby D Reed
Center for Clinical and Genetic Economics, USA
Infect Control Hosp Epidemiol 26:175-83. 2005..CONCLUSIONS: Community-dwelling, hemodialysis-dependent patients hospitalized with MRSA bacteremia face a higher mortality risk, longer hospital stays, and higher inpatient costs than do patients with MSSA bacteremia...
Long-term survival estimates for imatinib versus interferon-alpha plus low-dose cytarabine for patients with newly diagnosed chronic-phase chronic myeloid leukemiaKevin J Anstrom
Center for Clinical and Genetic Economics, Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina, USA
Cancer 101:2584-92. 2004..CONCLUSIONS: Assuming the relation between CCyR and survival with interferon-alpha holds for imatinib, higher CCyR rates with imatinib therapy will result in an estimated 6.23 life-years gained compared with treatment with IFN+LDAC...
The insurance effect on prescription drug expenditures among the elderly: findings from the 1997 Medical Expenditure Panel SurveyLesley H Curtis
Center for Clinical and Genetic Economics, Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina, USA
Med Care 42:439-46. 2004..By quantifying the insurance effect on expenditures among the elderly, the data reported here could reduce uncertainty in the budget estimation process...
Exploring options for improving healthcareStanley S Wang
Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27710, USA
Am Heart J 147:23-30. 2004....
Direct costs of allergic rhinitis in the United States: estimates from the 1996 Medical Expenditure Panel SurveyAmy W Law
Center for Clinical and Genetic Economics, Duke Clinical Research Institute, Durham, NC 27715, USA
J Allergy Clin Immunol 111:296-300. 2003..Individuals with no insurance coverage have higher total out-of-pocket prescription expenditures than those with coverage...
Analytic considerations in economic evaluations of multinational cardiovascular clinical trialsFrank M Torti
Center for Clinical and Genetic Economics, Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27715, USA
Value Health 9:281-91. 2006....
Sex differences in the use of implantable cardioverter-defibrillators for primary and secondary prevention of sudden cardiac deathLesley H Curtis
Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina 27715, USA
JAMA 298:1517-24. 2007..Previous studies of sex differences in the use of implantable cardioverter-defibrillators (ICDs) predate recent expansions in Medicare coverage and did not provide patient follow-up over multiple years...
Variations in coronary procedure utilization depending on body mass indexWilliam S Yancy
Center for Health Services Research in Primary Care, Veterans Affairs Medical Center, Durham, NC 27705, USA
Arch Intern Med 165:1381-7. 2005..The relationship between BMI and utilization of diagnostic or therapeutic procedures for coronary heart disease has not been examined...
Does the ownership of the admitting hospital make a difference? Outcomes and process of care of Medicare beneficiaries admitted with acute myocardial infarctionFrank A Sloan
Department of Economics, Duke University, Durham, North Carolina 27708, USA
Med Care 41:1193-205. 2003..Concerns have been expressed about quality of for-profit hospitals and their use of expensive technologies...
Using item banks to construct measures of patient reported outcomes in clinical trials: investigator perceptionsKathryn E Flynn
Center for Clinical and Genetic Economics, Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC 27715, USA
Clin Trials 5:575-86. 2008....
Perceptions of racial and ethnic differences in access to healthcareDamon M Seils
Center for Clinical and Genetic Economics, Duke University, Durham, NC 27715, USA
N C Med J 65:350-2. 2004
Assessment of left ventricular function in older Medicare beneficiaries with newly diagnosed heart failureLesley H Curtis
Duke Clinical Research Institute and Department of Medicine, Duke University School of Medicine, Durham, NC 27715, USA
Circ Cardiovasc Qual Outcomes 4:85-91. 2011..Little is known about the extent to which left ventricular function is assessed in real-world settings...
The correlation between patient characteristics and expectations of benefit from Phase I clinical trialsKevin P Weinfurt
Center for Clinical and Genetic Economics, Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina 27715, USA
Cancer 98:166-75. 2003..The authors examined a range of patient characteristics to determine which factors were associated with greater expectations of benefit from Phase I trials...
Expectations of benefit in early-phase clinical trials: implications for assessing the adequacy of informed consentKevin P Weinfurt
Center for Clinical and Genetic Economics, Duke Clinical Research Institute, Durham, NC 27715, USA
Med Decis Making 28:575-81. 2008..There is concern that participants misunderstand the trials to which they have consented, which is based on assumptions about what patients mean when responding to questions about likelihood of benefit...
Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantationEric L Eisenstein
Department of Medicine, Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27710, USA
JAMA 297:159-68. 2007..Recent studies of drug-eluting intracoronary stents suggest that current antiplatelet regimens may not be sufficient to prevent late stent thrombosis...
Cost-effectiveness of zoledronic acid for the prevention of skeletal complications in patients with prostate cancerShelby D Reed
Center for Clinical and Genetic Economics, Duke Clinical Research Institute, Duke University Medical Center Durham, North Carolina, USA
J Urol 171:1537-42. 2004..However, the cost-effectiveness ratios for bisphosphonates are higher than commonly cited thresholds for conferring cost-effectiveness...
Risks of mortality, myocardial infarction, bleeding, and stroke associated with therapies for age-related macular degenerationLesley H Curtis
Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina 27715, USA
Arch Ophthalmol 128:1273-9. 2010..To examine associations between therapies for age-related macular degeneration and risks of all-cause mortality, incident myocardial infarction, bleeding, and incident stroke...
End point selection in acute decompensated heart failure clinical trials: economic end pointsShelby D Reed
Department of Medicine, Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC 27715, USA
Heart Fail Clin 7:529-37. 2011..Integrating economic end points with concrete clinical outcomes postdischarge will provide meaningful data to evaluate a treatment's incremental value in the setting of ADHF...
Physician-industry cooperation in the medical device industryAaron K Chatterji
Duke University, in Durham, North Carolina, USA
Health Aff (Millwood) 27:1532-43. 2008..This finding supports the maintenance of an open environment for physician-industry collaboration in the medical device discovery process...
Patient and implanting physician factors associated with mortality and complications after implantable cardioverter-defibrillator implantation, 2002-2005Sana M Al-Khatib
Duke Clinical Research Institute, Department of Medicine, Duke University School of Medicine, Durham, NC 27715, USA
Circ Arrhythm Electrophysiol 1:240-9. 2008..We examined patient and implanting physician factors associated with outcomes of ICD therapy in Medicare beneficiaries from 2002 through 2005...
Health-related quality of life among patients with breast cancer receiving zoledronic acid or pamidronate disodium for metastatic bone lesionsKevin P Weinfurt
Center for Clinical and Genetic Economics, Duke Clinical Research Institute, Durham, North Carolina 27715, USA
Med Care 42:164-75. 2004..Research on individual differences in health-related quality of life (HRQOL) can identify intervention targets and important covariates in analyses of treatment outcomes...
Spending on postapproval drug safetyDavid B Ridley
Fuqua School of Business, Duke University, Durham, North Carolina, USA
Health Aff (Millwood) 25:429-36. 2006..This study offers information for the debate on proposed changes to safety surveillance...
Clinical effectiveness of beta-blockers in heart failure: findings from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure) RegistryAdrian F Hernandez
Duke Clinical Research Institute, Durham, NC 27715, USA
J Am Coll Cardiol 53:184-92. 2009..We sought to examine associations between initiation of beta-blocker therapy and outcomes among elderly patients hospitalized for heart failure...
The effect of dementia on outcomes and process of care for Medicare beneficiaries admitted with acute myocardial infarctionFrank A Sloan
Department of Economics and Clinical Research Institute, Duke University, Durham, North Carolina 27708, USA
J Am Geriatr Soc 52:173-81. 2004..To determine differences in mortality after admission for acute myocardial infarction (AMI) and in use of noninvasive and invasive treatments for AMI between patients with and without dementia...
Decision making and quality of life in the treatment of cancer: a reviewS Yousuf Zafar
Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA
Support Care Cancer 17:117-27. 2009..We present an overview of the literature related to patient and physician decision making and quality of life in patients with advanced cancer, and we propose approaches to future decision-making models in cancer treatment...
Research Grants
- ACTION EQOL STUDYKevin Schulman; Fiscal Year: 2007..The trial will take place over 5 years with an initial 6 months for planning, training, and implementation; 3 years of enrollment; 1 year of follow-up; and 6 months for close out, analysis, and presentation. ..
